Dynavax Current Deferred Revenue vs Net Tangible Assets Analysis
DVAX Stock | USD 11.74 0.02 0.17% |
Dynavax Technologies financial indicator trend analysis is much more than just examining Dynavax Technologies latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Dynavax Technologies is a good investment. Please check the relationship between Dynavax Technologies Current Deferred Revenue and its Net Tangible Assets accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dynavax Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Dynavax Stock please use our How to Invest in Dynavax Technologies guide.
Current Deferred Revenue vs Net Tangible Assets
Current Deferred Revenue vs Net Tangible Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Dynavax Technologies Current Deferred Revenue account and Net Tangible Assets. At this time, the significance of the direction appears to have almost no relationship.
The correlation between Dynavax Technologies' Current Deferred Revenue and Net Tangible Assets is 0.18. Overlapping area represents the amount of variation of Current Deferred Revenue that can explain the historical movement of Net Tangible Assets in the same time period over historical financial statements of Dynavax Technologies, assuming nothing else is changed. The correlation between historical values of Dynavax Technologies' Current Deferred Revenue and Net Tangible Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Current Deferred Revenue of Dynavax Technologies are associated (or correlated) with its Net Tangible Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Tangible Assets has no effect on the direction of Current Deferred Revenue i.e., Dynavax Technologies' Current Deferred Revenue and Net Tangible Assets go up and down completely randomly.
Correlation Coefficient | 0.18 |
Relationship Direction | Positive |
Relationship Strength | Insignificant |
Current Deferred Revenue
Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.Net Tangible Assets
The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.Most indicators from Dynavax Technologies' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Dynavax Technologies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dynavax Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Dynavax Stock please use our How to Invest in Dynavax Technologies guide.At this time, Dynavax Technologies' Selling General Administrative is fairly stable compared to the past year. Enterprise Value Over EBITDA is likely to rise to 95.41 in 2024, whereas Tax Provision is likely to drop slightly above 945.2 K in 2024.
2023 | 2024 (projected) | Interest Income | 26.8M | 28.1M | Non Recurring | 15.4M | 16.1M |
Dynavax Technologies fundamental ratios Correlations
Click cells to compare fundamentals
Dynavax Technologies Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Dynavax Technologies fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 279.1M | 353.3M | 1.0B | 985.9M | 997.1M | 1.0B | |
Total Stockholder Equity | 8.3M | 58.7M | 222.4M | 581.0M | 622.1M | 653.2M | |
Retained Earnings | (1.2B) | (1.3B) | (1.2B) | (924.2M) | (930.6M) | (884.1M) | |
Other Assets | 3.6M | 3.8M | 368.9K | 3.5M | 3.2M | 3.0M | |
Common Stock Shares Outstanding | 72.0M | 100.8M | 133.0M | 150.8M | 128.7M | 135.2M | |
Liabilities And Stockholders Equity | 279.1M | 353.3M | 1.0B | 985.9M | 997.1M | 1.0B | |
Other Stockholder Equity | 1.2B | 1.4B | 1.4B | 1.5B | 1.6B | 1.6B | |
Total Liab | 270.8M | 294.6M | 816.9M | 404.8M | 375.0M | 393.8M | |
Other Current Liab | 43.8M | 32.6M | 201.4M | 143.2M | 24K | 22.8K | |
Total Current Liabilities | 53.0M | 77.4M | 556.4M | 150.1M | 62.2M | 58.2M | |
Accounts Payable | 9.3M | 3.3M | 2.6M | 3.2M | 5.2M | 3.1M | |
Cash | 39.9M | 32.1M | 436.2M | 202.0M | 150.3M | 157.8M | |
Short Term Investments | 111.2M | 133.0M | 109.8M | 422.4M | 592.0M | 621.6M | |
Other Current Assets | (8.9M) | (22.7M) | (131.8M) | 85.6M | 19.0M | 19.9M | |
Common Stock | 84K | 110K | 123K | 128K | 130K | 83.9K | |
Property Plant Equipment | 32.0M | 30.6M | 61.0M | 37.6M | 43.2M | 45.4M | |
Property Plant And Equipment Net | 32.0M | 57.2M | 61.0M | 63.3M | 61.6M | 64.7M | |
Net Debt | 176.6M | 185.8M | (178.8M) | 56.0M | 106.6M | 112.0M | |
Non Current Assets Total | 86.7M | 124.5M | 432.0M | 302.0M | 138.0M | 144.9M | |
Non Currrent Assets Other | 50.1M | 65.1M | 368.9M | 236.7M | 74.3M | 46.9M | |
Cash And Short Term Investments | 151.1M | 165.0M | 546.0M | 624.4M | 742.3M | 779.4M | |
Common Stock Total Equity | 84K | 110K | 123K | 128K | 147.2K | 85.0K | |
Non Current Liabilities Total | 217.7M | 217.2M | 260.5M | 254.8M | 312.8M | 328.5M | |
Property Plant And Equipment Gross | 62.3M | 57.2M | 61.0M | 63.3M | 93.4M | 98.1M | |
Total Current Assets | 192.4M | 228.7M | 607.3M | 683.8M | 859.1M | 902.1M | |
Accumulated Other Comprehensive Income | (2.4M) | 273K | (2.3M) | (5.4M) | (2.1M) | (2.2M) | |
Net Receivables | 8.9M | 22.7M | 131.8M | 147.5M | 44.5M | 46.8M | |
Other Liab | 1.3M | 2.6M | 5.7M | 384K | 345.6K | 328.3K | |
Good Will | 2.1M | 2.3M | 2.1M | 2.0M | 2.1M | 1.8M | |
Inventory | 41.3M | 63.7M | 61.3M | 59.4M | 53.3M | 56.0M | |
Short Long Term Debt Total | 216.4M | 217.8M | 257.4M | 258.0M | 256.9M | 148.6M | |
Long Term Debt | 178.6M | 179.8M | 220.5M | 221.6M | 222.7M | 233.8M | |
Net Tangible Assets | 3.7M | 56.4M | 220.2M | 579.0M | 665.9M | 699.2M | |
Retained Earnings Total Equity | (1.2B) | (1.3B) | (1.2B) | (924.2M) | (831.8M) | (873.4M) | |
Capital Surpluse | 1.2B | 1.4B | 1.4B | 1.5B | 1.7B | 1.1B | |
Non Current Liabilities Other | 39.1M | 37.4M | 5.7M | 33.2M | 74K | 70.3K |
Pair Trading with Dynavax Technologies
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Dynavax Technologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dynavax Technologies will appreciate offsetting losses from the drop in the long position's value.Moving together with Dynavax Stock
0.75 | EGRX | Eagle Pharmaceuticals | PairCorr |
0.83 | JNJ | Johnson Johnson Financial Report 18th of July 2024 | PairCorr |
Moving against Dynavax Stock
0.8 | QLI | Qilian International | PairCorr |
0.67 | SNDL | SNDL Inc Financial Report 20th of May 2024 | PairCorr |
0.66 | CGC | Canopy Growth Corp Financial Report 27th of June 2024 | PairCorr |
0.59 | IMCC | Im Cannabis Corp | PairCorr |
0.5 | PAHC | Phibro Animal Health Fiscal Year End 4th of September 2024 | PairCorr |
The ability to find closely correlated positions to Dynavax Technologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Dynavax Technologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Dynavax Technologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Dynavax Technologies to buy it.
The correlation of Dynavax Technologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Dynavax Technologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Dynavax Technologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Dynavax Technologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dynavax Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Dynavax Stock please use our How to Invest in Dynavax Technologies guide.Note that the Dynavax Technologies information on this page should be used as a complementary analysis to other Dynavax Technologies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Complementary Tools for Dynavax Stock analysis
When running Dynavax Technologies' price analysis, check to measure Dynavax Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dynavax Technologies is operating at the current time. Most of Dynavax Technologies' value examination focuses on studying past and present price action to predict the probability of Dynavax Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dynavax Technologies' price. Additionally, you may evaluate how the addition of Dynavax Technologies to your portfolios can decrease your overall portfolio volatility.
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |
Is Dynavax Technologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dynavax Technologies. If investors know Dynavax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dynavax Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.77) | Earnings Share (0.05) | Revenue Per Share 1.804 | Quarterly Revenue Growth (0.70) | Return On Assets (0.02) |
The market value of Dynavax Technologies is measured differently than its book value, which is the value of Dynavax that is recorded on the company's balance sheet. Investors also form their own opinion of Dynavax Technologies' value that differs from its market value or its book value, called intrinsic value, which is Dynavax Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dynavax Technologies' market value can be influenced by many factors that don't directly affect Dynavax Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dynavax Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dynavax Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dynavax Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.